Strengthens ECI’s senior advisory expertise across quality, regulatory, and strategic growth initiatives
Enhanced Compliance Inc. (ECI), a global life sciences partner delivering integrated quality, regulatory, and compliance expertise—combined with hands-on engineering execution and advanced packaging and laboratory testing—today announced the appointment of Khalid Raja (Raj) as Senior Vice President, Strategic Growth & Advisory, effective April 13, 2026.”Khalid brings a rare combination of deep technical expertise, global leadership experience, and the ability to translate complex regulatory and quality challenges into actionable strategies,” said Brijesh Patel, Chief Executive Officer of ECI. “His background leading large-scale quality and compliance functions across some of the most respected companies in our industry will be instrumental as we continue to expand our capabilities and support clients through increasingly complex product and regulatory landscapes.”
Raj brings more than three decades of progressive leadership experience across quality, regulatory affairs, and global operations within the medical device and life sciences industry. He most recently served as Global Vice President of Quality & Compliance for Robotics and Digital Surgery at Johnson & Johnson, where he led quality and compliance strategy for advanced technology platforms. Prior to that, he held senior leadership roles at Dentsply Sirona and Philips, as well as Bausch & Lomb (a Valeant company) and Boston Scientific, where he was responsible for global quality and regulatory functions, driving enterprise-wide transformation initiatives, regulatory approvals, and operational excellence across complex manufacturing and supply chain environments.
Throughout his career, Raj has built and led global teams of significant scale, implemented robust quality management systems across international operations, and guided organisations through regulatory remediation, product commercialisation and compliance transformation efforts. His experience spans product development, manufacturing, supply chain, international regions and distribution, regulatory affairs, and pre- and post-market quality—bringing a uniquely integrated perspective to addressing complex regulatory and operational challenges.
In his role at ECI, Raj will serve as a senior strategic advisor and growth leader, working closely with clients to shape regulatory and quality strategies, support complex engagements, and drive growth across strategic accounts and key markets. He will also play a key role in advancing thought leadership and helping clients build scalable, high-performing quality systems.
“I’m excited to join ECI at a time when life sciences organisations are navigating increasing regulatory complexity and operational demands,” said Raj. “ECI’s model—combining quality, regulatory, and engineering expertise with testing lab and commercialisation readiness—positions it uniquely to support clients across the full product lifecycle. I look forward to helping organisations build stronger, more resilient systems while accelerating their path to market.”
About ECI
Enhanced Compliance Inc. (ECI) is a global life sciences partner delivering integrated quality, regulatory, and compliance expertise, combined with hands-on engineering execution and advanced packaging and laboratory testing. ECI works alongside medical device, pharmaceutical, biotechnology, and combination product companies across the full product lifecycle, from development and validation through post-market and remediation, helping teams solve complex challenges, strengthen quality systems, and ensure product readiness in highly regulated environments. For more than a decade, ECI has helped life sciences companies solve complex challenges across the product life cycle, enabling them to accelerate timelines, reduce risk, and bring safe, effective products to market with confidence.
